Q: What is Inlyta used for?

Inlyta is used to treat advanced renal cell carcinoma .

Q: What are the active ingredients in Inlyta?

The active ingredient in Inlyta is axitinib .

Q: What are the side effects of Inlyta?

Common side effects of Inlyta may include: diarrhea hypertension fatigue and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Inlyta?

Inlyta belongs to the tyrosine kinase inhibitor drug class.

Q: What is the dosage of Inlyta and how do I take it?

Administration Instructions Inlyta is a tablet taken by mouth. It is usually taken twice daily, with or without food. It is important to follow the specific schedule provided by your healthcare provider. Swallow tablets whole with a full glass of water. Do not crush, chew, or break the tablets. Try to take your doses at the same times each day to maintain consistent levels of the medication in your system. Missed Doses and Vomiting If you miss a dose, skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for a missed one. If you vomit after taking a dose of Inlyta, do not take an extra dose to replace it. Simply wait and take your next scheduled dose at the usual time.

Q: What is the FDA approval status of Inlyta?

FDA Approval History Inlyta received its initial approval from the U.S. Food and Drug Administration (FDA) in January 2012. It was originally indicated for the treatment of advanced renal cell carcinoma (RCC) in patients who had failed one prior systemic therapy. Approved Indications The FDA has expanded the approved uses of Inlyta to include both monotherapy and combination treatments for kidney cancer: Advanced Renal Cell Carcinoma: Used as a single agent for patients whose cancer has progressed after one prior systemic treatment. Combination with Pembrolizumab: Approved for use with pembrolizumab as a first-line treatment for patients with advanced RCC. Combination with Avelumab: Approved for use with avelumab as a first-line treatment for patients with advanced RCC. Regulatory Oversight Inlyta is classified as a kinase inhibitor. It is available only by prescription and does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program required by the FDA. Clinical use is monitored for safety, particularly regarding its effects on blood pressure and vascular health.

Question 1

What is Inlyta?

Accepted Answer

Inlyta is a type of medication called a kinase inhibitor. It functions by blocking specific proteins that signal cancer cells to multiply and by inhibiting the development of new blood vessels that tumors need to grow and survive.

By interfering with these signaling pathways, the medication helps to limit the progression and spread of the disease. It is designed to target the underlying biological processes that allow tumors to expand within the body.

Question 2

What is Inlyta used for?

Accepted Answer

Inlyta is used to treat advanced renal cell carcinoma.

Question 3

How does Inlyta work?

Accepted Answer

Inlyta is a type of targeted therapy known as a tyrosine kinase inhibitor. It works by interfering with the specific processes that cancer cells use to grow and spread throughout the body.

The medication primarily works in two ways:

Blocking growth signals: It blocks the activity of certain proteins that send signals to cancer cells, telling them to multiply and divide. By stopping these signals, the drug helps slow or stop the growth of the cancer.
Restricting blood supply: It also interferes with the cancer's ability to create new blood vessels. Tumors require a dedicated blood supply to receive the nutrients and oxygen they need to expand. By inhibiting this process, the medication helps starve the tumor.

Because Inlyta targets these specific proteins rather than all cells in the body, it is categorized as a targeted treatment for certain types of advanced cancer.

Question 4

What are the active ingredients in Inlyta?

Accepted Answer

The active ingredient in Inlyta is axitinib.

Question 5

What are the side effects of Inlyta?

Accepted Answer

Common side effects of Inlyta may include:

diarrhea
hypertension
fatigue
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Inlyta?

Accepted Answer

Inlyta belongs to the tyrosine kinase inhibitor drug class.

Question 7

What is the dosage of Inlyta and how do I take it?

Accepted Answer

Administration Instructions

Inlyta is a tablet taken by mouth. It is usually taken twice daily, with or without food. It is important to follow the specific schedule provided by your healthcare provider.

Swallow tablets whole with a full glass of water.
Do not crush, chew, or break the tablets.
Try to take your doses at the same times each day to maintain consistent levels of the medication in your system.

Missed Doses and Vomiting

If you miss a dose, skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for a missed one.

If you vomit after taking a dose of Inlyta, do not take an extra dose to replace it. Simply wait and take your next scheduled dose at the usual time.

Question 8

Is Inlyta safe during pregnancy and breastfeeding?

Accepted Answer

Inlyta can cause harm to a fetus if taken during pregnancy. Animal studies have shown that the medication can lead to birth defects or fetal death. It is important to inform a healthcare provider if you are pregnant or planning to become pregnant before starting this medication.

Contraception Requirements

Because of the risks to a developing fetus, healthcare providers recommend the following precautions regarding birth control:

Females: Women who are able to become pregnant should use effective birth control during treatment and for at least 1 week after the final dose.
Males: Men with female partners who are able to become pregnant should use effective birth control during treatment and for at least 1 week after the final dose.

It is not known whether Inlyta passes into human breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment. Patients should wait at least 2 weeks after their last dose of Inlyta before beginning or resuming breastfeeding.

Question 9

What forms and strengths does Inlyta come in?

Accepted Answer

Inlyta is available as a film-coated tablet that is taken by mouth. This medication is typically swallowed whole and is not currently offered in other forms such as oral liquids or injectable solutions.

Oral tablet

Question 10

What is the FDA approval status of Inlyta?

Accepted Answer

FDA Approval History

Inlyta received its initial approval from the U.S. Food and Drug Administration (FDA) in January 2012. It was originally indicated for the treatment of advanced renal cell carcinoma (RCC) in patients who had failed one prior systemic therapy.

Approved Indications

The FDA has expanded the approved uses of Inlyta to include both monotherapy and combination treatments for kidney cancer:

Advanced Renal Cell Carcinoma: Used as a single agent for patients whose cancer has progressed after one prior systemic treatment.
Combination with Pembrolizumab: Approved for use with pembrolizumab as a first-line treatment for patients with advanced RCC.
Combination with Avelumab: Approved for use with avelumab as a first-line treatment for patients with advanced RCC.

Regulatory Oversight

Inlyta is classified as a kinase inhibitor. It is available only by prescription and does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program required by the FDA. Clinical use is monitored for safety, particularly regarding its effects on blood pressure and vascular health.

Question 11

What should I know about Inlyta and cost?

Accepted Answer

Insurance and Prescription Status

Inlyta is a brand-name medication available only with a doctor's prescription. As a specialized treatment for advanced kidney cancer, its cost is primarily determined by the terms of a patient's health insurance policy, including deductibles and co-insurance rates.

Availability

Because Inlyta is a specialty drug, it may be dispensed through specific pharmacies rather than standard local drugstores. Healthcare providers often work with patients to identify the most appropriate way to fill the prescription based on their insurance requirements.

Financial Assistance

Financial assistance or patient support programs may be available for those who have difficulty covering the cost of the medication. Patients are encouraged to discuss these options with their healthcare provider or the manufacturer to determine eligibility.

Inlyta

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Inlyta

Hospitals.net Disclosure